World’s first weekly insulin injection coming to Canada in 2 weeks, manufacturer says

The Canadian Press  17/06/2024 04:00 Many people with diabetes in Canada will soon be able to take insulin once a week instead of daily, drug manufacturer Novo Nordisk announced on Monday. Insulin icodec, which will be sold under the brand name Awiqli, is the first once-a-week basal insulin injection in the world and it will be available across the country starting June 30, the company told The Canadian Press ahead of the announcement. Canada is the first country to get the product, which was approved by Health Canada in March for the treatment of adults with Type 1 and Type 2 diabetes. “I think it’s a very big deal,” said Dr. Harpreet Bajaj, head of the clinical practice guidelines steering committee at Diabetes Canada. “(It’s) huge for reducing the burden…

This content is for Yearly Subscription, Yearly Subscription – Corporate, Print Subscription Only, and Canada Print and Online members only.
Register
Already a member? Log in here

Add Your Voice

Is there more to this story? We'd like to hear from you about this or any other stories you think we should know about. Contribute your voice on our contribute page.